Dr. Nathan Fischel

 

 

Lectures & Presentations

(Post 1991; Excludes lectures at all Los Angeles based institutions)

 

  • Invited Speaker, "Molecular basis of deafness: General approaches and specific case of a pedigree with mitochondrially-inherited deafness". Plenary lecture at the 3rd Asian-Pacific Congress on Deafness, Pattaya, Thailand, 8/92.

  • Visiting Professor, "Mitochondrial genetics and mitochondrial pathology". Pediatric Grand Rounds, Siriraj Hospital, Bangkok, Thailand, 8/92.

  • Visiting Professor, "Molecular genetics and prenatal diagnosis of hemoglobinopathies". Hematology-Thalassemia Foundation, Siriraj Hospital, Bangkok, Thailand, 8/92.

  • Invited Speaker, "Medical genetics and molecular diagnosis: Current status and future prospects". Beckman Technical Symposium, Pala Mesa Resort, CA, 8/92.

  • Visiting Professor, "Mitochondrial genetics and congenital and acquired deafness". Pediatric Grand Rounds, Beilinson Medical Center, Tel Aviv, 3/94.

  • Invited Discussant, "Aminoglycoside ototoxicity". 'Human olfaction and audition: Parallels and emerging research strategies' at the Wellcome Centre for Medical Science, London, U.K., 5/94.

  • Keynote Scientific Address, "Mitochondrial genetics and deafness: A tale of the unexpected". Advisory Council of the National Institute of Deafness and Communication Disorders. Bethesda, MD, 5/94.

  • Invited Professor, "Mitochondrial genetics and deafness". Hearing and Chemical Senses Research Seminar, Kresge Hearing Research Institute, Ann Arbor, MI, 8/94.

  • Invited Speaker, "Mitochondrial genetics and deafness". Otolaryngology Grand Rounds, UCSD, La Jolla, CA, 8/94

  • Invited Speaker, "Mitochondrial genetics and deafness". Hereditary Deafness Symposium at the "American Society of Human Genetics" meeting, Montreal, Canada, 10/94.

  • Chairman of Plenary Session on "Genetic hearing loss and risk factors". 4th Asia Pacific Congress on Deafness. Manila, Philippines, 11/94.

  • Invited Speaker, "Molecular basis and prevention of aminoglycoside ototoxicity". 4th Asia Pacific Congress on Deafness. Manila, Philippines, 12/94.

  • Invited Speaker, "Localization of the gene for Familial Mediterranean Fever by genetic and physical mapping". Plenary lecture, Arthritis Foundation Research Conference, Chicago, IL, 5/95.

  • Chairman of Workshop on "Molecular Genetics and Gene Mapping". Arthritis Foundation Research Conference, Chicago, IL, 5/95.

  • Invited Speaker, "Mitochondrial genetics and deafness: A tale of the unexpected". Otolaryngology Research Seminar, Baylor College of Medicine, Houston, TX, 8/95.

  • Invited Speaker, "A mitochondrial mutation causing deafness and predisposition to aminoglycoside ototoxicity". Plenary lecture, The Molecular Biology of Hearing and Deafness, Bethesda, MD, 10/95.

  • Invited Speaker, "A genome wide search for Crohn's disease susceptibility genes". Plenary lecture, Development of Novel Anti-Inflammatory Therapeutics for Inflammatory Bowel Disease - IBC conference, Philadelphia, PA, 6/96.

  • Invited Professor, "Mitochondrial genetics and deafness: A tale of the unexpected". Keynote speaker, 1st Bloedel Research Center Symposium, Seattle, WA, 6/96.

  • Invited Speaker, "Mitochondrial mutations and non-syndromic hearing loss a missing link". Workshop, International Society of Human Genetics, Rio de Janeiro, Brazil, 8/96.

  • Invited discussant, "How genomics will revolutionize the Health Care industry". Panel discussion, Eighth Annual UCSD Connect Biotechnology/Biomedical Corporate Partnership Forum, La Jolla, CA, 11/96.

  • Visiting Professor, "The molecular genetic basis of hearing loss". Otolaryngology and Pediatric Special Lecture, Hadassah Hospital, Jerusalem, Israel, 8/97.

  • Visiting Professor, "Positional cloning of disease genes". Medical Genetics Research Lecture. Rabin Medical Center, Petah Tikvah, Israel, 8/97.

  • Invited Speaker, "Mitochondrial mutations and non-syndromic hearing loss". Workshop, American Society of Human Genetics meeting, Baltimore, MD, 10/97.

  • Invited Speaker, "Mitochondrial mutations and hearing loss". Plenary lecture at the 'Cell and Molecular Biology of the Ear' Symposium. Passadena, CA, 4/98.

  • Invited Speaker, "Genetic factors in aminoglycoside toxicity". Plenary lecture at 'Ototoxicity: Basic research and clinical applications' Symposium. Bari, Italy, 6/98.

  • Visiting Professor, "Maternally inherited hearing loss Biology and Clinical Implications'". Inauguration lecture for new Research Laboratory, University of Florence, Italy, 6/98.

  • Invited Speaker, “Elucidation of genetic pathways between primary mitochondrial mutations and the deafness phenotype”. Third Conference on the Molecular Biology of Hearing and Deafness. Bethesda, MD, 10/98.

  • Invited Speaker, “Mitochondrial mutations and hearing loss: From genotype to phenotype”. Plenary lecture at the ‘Society for Inherited Metabolic Disorders’ annual meeting. Lake Lanier Islands, GA, 3/99.

  • Visiting Professor, “Mitochondrial genetics: From phenotype to genotype, and back”. Grand Rounds, Whitaker Cardiovascular Institute, Boston University School of Medicine. Boston, MA, 6/99.

  • Invited Speaker, “Mitochondrial mutations and hearing loss: From phenotype to genotype, and back”. Plenary lecture at the NIH symposium ‘Mitochondrial diseases from bench to bedside’. Bethesda, MD, 10/99.

  • Invited Speaker, “Mitochondrial Deafness”. Workshop, American College of Medical Genetics meeting, Palm Springs, CA, 3/00.

  • Invited Speaker, “Mitochondrial deafness as a paradigm to understand the tissue specificity and variable clinical severity of mitochondrial disorders”. Plenary lecture at the Colloquium on Mitochondria and Myopathies, Halle, Germany, 4/00.

  • Visiting Professor, “Mitochondrial deafness as a paradigm for mitochondrial diseases”. Lecture at the Max-Delbrueck-Center, Max-Planck-Society, Berlin, Germany, 4/00.

  • Invited Speaker, “PIPE investments in biotechnology” at Biofinancing 2000 Turning Trends into Opportunities, Dana Point, CA, 9/00.

  • Invited Speaker, “A nuclear-mitochondrial DNA interaction affecting hearing impairment in mice”. Oral presentation at the American Society of Human Genetics meeting, Philadelphia, PA, 10/00.

  • Panelist, “Investing in IPO’s: Many hidden risks”, at The 3rd Southern California Biotechnology Conference, Los Angeles, CA, 2/01.

  • Invited Speaker, “Investing in Biotechnology: The art of company valuations”, at Biofinancing 2001, Iselin, NJ, 3/01.

  • Invited Speaker, “How to evaluate potential investments From the investor side”, at The 2001 BioInvestment Forum, Boston, MA, 6/01.

  • Invited Speaker, “Maternally inherited deafness in man and mouse”. Fourth Conference on the Molecular Biology of Hearing and Deafness. Bethesda, MD, 10/01.

  • Invited Speaker, “The use of hedge funds in Life Sciences to drive returns”, 2nd Annual Biofinancing Turning the Focus Toward Access to Capital, San Diego, CA, 11/01.

  • Invited Speaker, “Genetic factors in aminoglycoside ototoxicity”. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, 9/03.

  • Invited Speaker, “From the patient to the bench, and back again”, NIDCD Workshop for new physician investigators in communication disorders: strategies for success, Bethesda, MD, 10/07.

 

 

Back to Dr. Fischel's Biography